Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials) ASBrS 4 Mins Read What Are CDK4/6 Inhibitors? CDK4/6 inhibitors, such as abemaciclib and ribociclib, are changing breast cancer treatment for HR+/HER2- early-stage patients.…
Abemaciclib in Focus: A Look at monarchE Trial Breast Cancer 12 Mins Read Abemaciclib, a CDK4 & 6 inhibitor, has shown a sustained benefit in invasive disease-free survival in high-risk EBC, as seen…
monarchE Trial Efficacy and Safety Results by Age in High-risk Early Breast Cancer Breast Cancer 3 Mins Read Erika Hamilton, MD, a preeminent expert from the Sarah Cannon Research Institute, has recently conducted a study evaluating the efficacy…
